Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M608572200 on November 14, 2006

J. Biol. Chem., Vol. 282, Issue 3, 1891-1904, January 19, 2007
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
282/3/1891    most recent
M608572200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Meadows, N. A.
Right arrow Articles by Cassady, A. I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Meadows, N. A.
Right arrow Articles by Cassady, A. I.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

The Expression of Clcn7 and Ostm1 in Osteoclasts Is Coregulated by Microphthalmia Transcription Factor*

Nicholas A. Meadows{ddagger}§, Sudarshana M. Sharma, Geoffrey J. Faulkner{ddagger}, Michael C. Ostrowski, David A. Hume{ddagger}§, and Alan I. Cassady{ddagger}§1

From the {ddagger}Institute for Molecular Biosciences, the University of Queensland, St. Lucia, Queensland 4072, Australia, §Cooperative Research Centre for Chronic Inflammatory Diseases, St. Lucia, Queensland 4072, Australia, and the Department of Molecular Genetics, Ohio State University, Columbus, Ohio 43210

Microphthalmia transcription factor (MITF) regulates osteoclast function by controling the expression of genes, including tartrate-resistant acid phosphatase (TRAP) and cathepsin K in response to receptor activator of nuclear factor-{kappa}B ligand (RANKL)-induced signaling. To identify novel MITF target genes, we have overexpressed MITF in the murine macrophage cell line RAW264.7 subclone 4 (RAW/C4) and examined the gene expression profile after sRANKL-stimulated osteoclastogenesis. Microarray analysis identified a set of genes superinduced by MITF overexpression, including Clcn7 (chloride channel 7) and Ostm1 (osteopetrosis-associated transmembrane protein 1). Using electrophoretic mobility shift assays, we identified two MITF-binding sites (M-boxes) in the Clcn7 promoter and a single M-box in the Ostm1 promoter. An anti-MITF antibody supershifted DNA-protein complexes for promoter sites in both genes, whereas MITF binding was abolished by mutation of these sites. The Clcn7 promoter was transactivated by coexpression of MITF in reporter gene assays. Mutation of one Clcn7 M-box prevented MITF transactivation, but mutation of the second MITF-binding site only reduced basal activity. Chromatin immunoprecipitation assays confirmed that the two Clcn7 MITF binding and responsive regions in vitro bind MITF in genomic DNA. The expression of Clcn7 is repressed in the dominant negative mutant Mitf mouse, mi/mi, indicating that the dysregulated bone resorption seen in these mice can be attributed in part to transcriptional repression of Clcn7. MITF regulation of the TRAP, cathepsin K, Clcn7, and Ostm1 genes, which are critical for osteoclast resorption, suggests that the role of MITF is more significant than previously perceived and that MITF may be a master regulator of osteoclast function and bone resorption.


Received for publication, September 6, 2006 , and in revised form, November 10, 2006.

* This work was supported by the National Health and Medical Research Council Grant 210261 and by the Cooperative Research Centre for Chronic Inflammatory Diseases, Australia. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 To whom correspondence should be addressed. Tel.: 61-7-3346-2076; Fax: 61-7-3346-2101; E-mail: I.Cassady{at}imb.uq.edu.au.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
H. Feng, T. Cheng, J. H. Steer, D. A. Joyce, N. J. Pavlos, C. Leong, J. Kular, J. Liu, X. Feng, M. H. Zheng, et al.
Myocyte Enhancer Factor 2 and Microphthalmia-associated Transcription Factor Cooperate with NFATc1 to Transactivate the V-ATPase d2 Promoter during RANKL-induced Osteoclastogenesis
J. Biol. Chem., May 22, 2009; 284(21): 14667 - 14676.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D. A. Hume, T. Sasmono, S. R. Himes, S. M. Sharma, A. Bronisz, M. Constantin, M. C. Ostrowski, and I. L. Ross
The Ewing Sarcoma Protein (EWS) Binds Directly to the Proximal Elements of the Macrophage-Specific Promoter of the CSF-1 Receptor (csf1r) Gene
J. Immunol., May 15, 2008; 180(10): 6733 - 6742.
[Abstract] [Full Text] [PDF]


Home page
IBMS BoneKEyHome page
M. H. Helfrich, J. C. Crockett, L. J. Hocking, and F. P. Coxon
The Pathogenesis of Osteoclast Diseases: Some Knowns, but Still Many Unknowns
IBMS BoneKEy, February 1, 2007; 4(2): 61 - 77.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2007 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement